Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mealis is a private regional life sciences and healthcare commercialization company operating across the Middle East, with entities in the United Arab Emirates, Lebanon, and Turkey. The company focuses on distribution, sales, marketing, regulatory support, and clinical/medical affairs services for global healthcare manufacturers rather than on discovering or developing its own therapeutics. Its portfolio spans pharmaceuticals, nutraceuticals, medical devices, digital health, surgical products, advanced therapeutics, infertility and women’s health solutions, wound care, and selected diagnostic products. Publicly available partner information indicates Mealis represents or works with manufacturers such as Mallinckrodt, KOEK Biotechnology, Mirion Technologies, Calmed, and ITM. Overall, Mealis appears to function as a commercial bridge for innovative healthcare products entering regional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mealis.